Holling Tjadine M, van Eggermond Marja C J A, Jager Martine J, van den Elsen Peter J
Division of Molecular Biology, Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.
Biochem Pharmacol. 2006 Nov 30;72(11):1570-6. doi: 10.1016/j.bcp.2006.06.034. Epub 2006 Aug 1.
Lack of expression of major histocompatibility complex (MHC) molecules of both classes is frequently noted on tumour cells . It is thought that in this way tumour cells escape immunosurveillance. The genes encoding both classes of MHC molecules are localized on the distal part of chromosome 6 (6p21.3). The class II transactivator (CIITA), encoded by the MHC2TA gene, is essential for transcriptional activation of all MHC-II genes, while it has a helper function in the transcriptional regulation of MHC-I genes (with the exception of human leukocyte antigen (HLA)-G) and of the gene encoding beta2-microglobulin (beta2m) . Here we discuss our current knowledge on the expression characteristics of MHC2TA and argue for an important role of epigenetic factors and mechanisms in the transcriptional silencing of MHC2TA in cancer cells.
两类主要组织相容性复合体(MHC)分子在肿瘤细胞上常常表现为表达缺失。人们认为肿瘤细胞以此方式逃避免疫监视。编码这两类MHC分子的基因定位于6号染色体(6p21.3)的远端。由MHC2TA基因编码的II类反式激活因子(CIITA)对于所有MHC-II基因的转录激活至关重要,而它在MHC-I基因(人类白细胞抗原(HLA)-G除外)以及编码β2-微球蛋白(β2m)的基因的转录调控中具有辅助功能。在此,我们讨论目前关于MHC2TA表达特征的知识,并论证表观遗传因素和机制在癌细胞中MHC2TA转录沉默中的重要作用。